ALB and neoplasm: The biodistribution of HSA–CDDP was analyzed 72 h after the last HSA–CDDP treatment as an antitumor effect (treatment administered every other day seven times, beginning 15 days after the first HSA–CDDP treatment) in normal mice and tumor-bearing mice.